CN Patent

CN121443610A — 一种plk1激酶抑制剂的盐型、晶型及其制备方法和应用

Assigned to Yantai Chuanghe Biotechnology Co ltd · Expires 2026-01-30 · 0y expired

What this patent protects

提供一种PLK1激酶抑制剂的盐型、晶型及其制备方法和应用。具体而言，提供了式I化合物的盐型、晶型、制备方法，以及在制备因PLK1激酶活性失调导致和/或与之相关的疾病的药物中的应用。

USPTO Abstract

提供一种PLK1激酶抑制剂的盐型、晶型及其制备方法和应用。具体而言，提供了式I化合物的盐型、晶型、制备方法，以及在制备因PLK1激酶活性失调导致和/或与之相关的疾病的药物中的应用。

Drugs covered by this patent

Patent Metadata

Patent number: CN121443610A
Jurisdiction: CN
Classification: —
Expires: 2026-01-30
Drug substance claim: No
Drug product claim: No
Assignee: Yantai Chuanghe Biotechnology Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.